PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 172 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $401,000 | – | 185,853 | +1858430.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 10 | -100.0% | 0.00% | -100.0% |
| Q1 2019 | $768,000 | -53.6% | 206,502 | -65.8% | 0.00% | -66.7% |
| Q4 2017 | $1,654,000 | +127.5% | 603,800 | +181.5% | 0.00% | +200.0% |
| Q3 2017 | $727,000 | -80.6% | 214,500 | -85.8% | 0.00% | -88.9% |
| Q2 2017 | $3,739,000 | -22.8% | 1,513,638 | -29.0% | 0.01% | -30.8% |
| Q1 2017 | $4,841,000 | +7.1% | 2,132,600 | 0.0% | 0.01% | -18.8% |
| Q4 2016 | $4,521,000 | -36.7% | 2,132,600 | 0.0% | 0.02% | -38.5% |
| Q3 2016 | $7,144,000 | +6.7% | 2,132,600 | 0.0% | 0.03% | -3.7% |
| Q2 2016 | $6,696,000 | -5.7% | 2,132,600 | 0.0% | 0.03% | -6.9% |
| Q1 2016 | $7,102,000 | +15.2% | 2,132,600 | +22.4% | 0.03% | 0.0% |
| Q4 2015 | $6,167,000 | +183.8% | 1,742,100 | +303.2% | 0.03% | +222.2% |
| Q3 2015 | $2,173,000 | – | 432,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |